234 related articles for article (PubMed ID: 25471038)
1. PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature.
Johnbeck CB; Knigge U; Kjær A
Future Oncol; 2014 Nov; 10(14):2259-77. PubMed ID: 25471038
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 18F-DOPA Versus 68Ga-DOTATOC as Preferred PET Imaging Tracer in Well-Differentiated Neuroendocrine Neoplasms.
Veenstra EB; de Groot DJA; Brouwers AH; Walenkamp AME; Noordzij W
Clin Nucl Med; 2021 Mar; 46(3):195-200. PubMed ID: 33323729
[TBL] [Abstract][Full Text] [Related]
3. A Cyanine-Bridged Somatostatin Hybrid Probe for Multimodal SSTR2 Imaging in Vitro and in Vivo: Synthesis and Evaluation.
Heing-Becker I; Grötzinger C; Beindorff N; Prasad S; Erdmann S; Exner S; Haag R; Licha K
Chembiochem; 2021 Apr; 22(7):1307-1315. PubMed ID: 33238069
[TBL] [Abstract][Full Text] [Related]
4. The utility of
Tirosh A; Kebebew E
Future Oncol; 2018 Jan; 14(2):111-122. PubMed ID: 29072093
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin Receptor Expression in Lung Neuroendocrine Tumors: An Analysis of DOTATATE PET Scans.
Al-Toubah T; Montilla-Soler J; El-Haddad G; Haider M; Strosberg J
J Nucl Med; 2023 Dec; 64(12):1895-1898. PubMed ID: 37797976
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging Theranostics of Neuroendocrine Tumors.
Fortunati E; Bonazzi N; Zanoni L; Fanti S; Ambrosini V
Semin Nucl Med; 2023 Jul; 53(4):539-554. PubMed ID: 36623974
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine Tumors: Diagnostics.
Sakellis C; Jacene HA
PET Clin; 2024 Jul; 19(3):325-339. PubMed ID: 38714399
[TBL] [Abstract][Full Text] [Related]
8. Exceptional Visualization of the Gallbladder on 68Ga-DOTANOC PET/CT Imaging.
Solanki R; Singh H; Kumar R
Clin Nucl Med; 2022 Jun; 47(6):e468-e469. PubMed ID: 35353720
[TBL] [Abstract][Full Text] [Related]
9. Investigation of imaging the somatostatin receptor by opening the blood-brain barrier with melittin - A feasibility study using positron emission tomography and [
Andersen IV; Bidesi NSR; Shalgunov V; Jørgensen JT; Gustavsson T; Strømgaard K; Ingemann Jensen AT; Kjær A; Herth MM
Nucl Med Biol; 2024; 132-133():108905. PubMed ID: 38555651
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects.
Park S; Parihar AS; Bodei L; Hope TA; Mallak N; Millo C; Prasad K; Wilson D; Zukotynski K; Mittra E
J Nucl Med; 2021 Oct; 62(10):1323-1329. PubMed ID: 34301785
[TBL] [Abstract][Full Text] [Related]
11. Incidental cardiac findings on somatostatin receptor PET/CT: What do they indicate and are they of clinical relevance?
Bobbio E; Dudás A; Bergström A; Esposito D; Angerås O; Taha A; van Essen M; Björkenstam M; Karason K; Bollano E; Bergh N; Polte CL
J Nucl Cardiol; 2022 Jun; 29(3):1159-1165. PubMed ID: 33502695
[TBL] [Abstract][Full Text] [Related]
12. PET/CT imaging of neuroendocrine tumors with (68)Gallium-labeled somatostatin analogues: An overview and single institutional experience from India.
Sharma P; Singh H; Bal C; Kumar R
Indian J Nucl Med; 2014 Jan; 29(1):2-12. PubMed ID: 24591775
[TBL] [Abstract][Full Text] [Related]
13. Beyond
Ninatti G; Mapelli P
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2246-2247. PubMed ID: 37221378
[No Abstract] [Full Text] [Related]
14. Somatostatin Receptor PET Imaging in Diffuse Pancreatic Neuroendocrine Tumor.
Zhao Q; Dong A; He T; Zuo C
Clin Nucl Med; 2023 May; 48(5):453-456. PubMed ID: 36754358
[TBL] [Abstract][Full Text] [Related]
15. PET Radiotracers in Atherosclerosis: A Review.
Blanchard I; Vootukuru N; Bhattaru A; Patil S; Rojulpote C
Curr Probl Cardiol; 2023 Nov; 48(11):101925. PubMed ID: 37392979
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 99mTc radiolabeled somatostatin antagonist with [
Opalinska M; Lezaic L; Decristoforo C; Kolenc P; Mikolajczak R; Studen A; Simoncic U; Virgolini I; Trofimiuk-Muldner M; Garnuszek P; Rangger C; Fani M; Glowa B; Skorkiewicz K; Hubalewska-Dydejczyk A
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4110-4111. PubMed ID: 37452871
[No Abstract] [Full Text] [Related]
17. Interaction of Radiopharmaceuticals with Somatostatin Receptor 2 Revealed by Molecular Dynamics Simulations.
Gervasoni S; Öztürk I; Guccione C; Bosin A; Ruggerone P; Malloci G
J Chem Inf Model; 2023 Aug; 63(15):4924-4933. PubMed ID: 37466559
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
